Structure based design of 4-(3-aminomethylphenyl)piperidinyl-1-amides: novel, potent, selective, and orally bioavailable inhibitors of βII tryptase

Add time:07/11/2019    Source:sciencedirect.com

Tryptase is a serine protease found almost exclusively in mast cells. It has trypsin-like specificity, favoring cleavage of substrates with an arginine (or lysine) at the P1 position, and has optimal catalytic activity at neutral pH. Current evidence suggests tryptase β is the most important form released during mast cell activation in allergic diseases. It is shown to have numerous pro-inflammatory cellular activities in vitro, and in animal models tryptase provokes broncho-constriction and induces a cellular inflammatory infiltrate characteristic of human asthma. Screening of in-house inhibitors of factor Xa (a closely related serine protease) identified β-amidoester benzamidines as potent inhibitors of recombinant human βII tryptase. X-ray structure driven template modification and exchange of the benzamidine to optimize potency and pharmacokinetic properties gave selective, potent and orally bioavailable 4-(3-aminomethyl phenyl)piperidinyl-1-amides.

We also recommend Trading Suppliers and Manufacturers of N,N-DI-BOC-4-AMINOMETHYL BENZAMIDINE (cas 217313-84-3). Pls Click Website Link as below: cas 217313-84-3 suppliers

Prev:A convenient synthesis of copper(II) bis[5-(pyridin-2-yl-methylidene)-2-thiohydantoin] complexes
Next:Synthesis and thermal decomposition of rare earth isovalerates and their solutions with amines as an effective pathway to obtain oxide nanomaterials)